46 related articles for article (PubMed ID: 25068730)
1. Synthesis and evaluation of N-heteroarylsubstituted triazolosulfonamides as carbonic anhydrase inhibitors.
Balci A; Arslan M; Nixha AR; Bilen C; Ergun A; Gençer N
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):377-82. PubMed ID: 25068730
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors.
Dizdaroglu Y; Albay C; Arslan T; Ece A; Turkoglu EA; Efe A; Senturk M; Supuran CT; Ekinci D
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):289-297. PubMed ID: 31797703
[TBL] [Abstract][Full Text] [Related]
3. Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.
Angeli A; Chiaramonte N; Manetti D; Romanelli MN; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):303-308. PubMed ID: 29280407
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Inhibitor Effect Novel Alkoxymethyl Derivatives of Dihetero Cycloalkanes on Carbonic Anhydrase and Acetylcholinesterase.
Farzaliyev V; Ertürk A; Abbasova M; Nabiyev O; Demir Y; Kızıltaş H; Sujayev A; Gülçin İ
Chem Biodivers; 2024 Jun; 21(6):e202400296. PubMed ID: 38575390
[TBL] [Abstract][Full Text] [Related]
5. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS
Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro inhibition effect of new pyrido[2,3-d]pyrimidine derivatives on erythrocyte carbonic anhydrase I and II.
Kuday H; Sonmez F; Bilen C; Yavuz E; Gençer N; Kucukislamoglu M
Biomed Res Int; 2014; 2014():594879. PubMed ID: 25165709
[TBL] [Abstract][Full Text] [Related]
7. IN SILICO STUDY OF NOVEL SULFONAMIDE DERIVATIVES BEARING A 1, 2, 4-TRIAZOLE MOIETY ACT AS CARBONIC ANHYDRASE INHIBITORS WITH PROMISING ANTI-CANCER ACTIVITY.
Abbas ZK; Naser NH; Atiya RN
Pol Merkur Lekarski; 2023; 51(5):527-532. PubMed ID: 38069854
[TBL] [Abstract][Full Text] [Related]
8. The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes.
Argan O; Çıkrıkçı K; Baltacı A; Gencer N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1359-1362. PubMed ID: 32567385
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and docking studies of benzenesulfonamide derivatives containing 1,2,3-triazole as potential ınhibitor of carbonic anhydrase I-II enzymes.
Güngör SA; Köse M; Tümer M; Türkeş C; Beydemir Ş
J Biomol Struct Dyn; 2023 Dec; 41(20):10919-10929. PubMed ID: 36576122
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors.
Çelik İ; Acar Çevik U; Küçükoğlu K; Nadaroglu H; Bostancı HE; Işık A; Özkay Y; Kaplancıklı ZA
Chem Biol Drug Des; 2024 Jan; 103(1):e14351. PubMed ID: 37697918
[TBL] [Abstract][Full Text] [Related]
11. Exploration of 3-aryl pyrazole-tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors.
Ommi O; Paoletti N; Bonardi A; Gratteri P; Bhalerao HA; Sau S; Nanduri S; Mohammed A; Kalia NP; Sonti R; Supuran CT; Yaddanapudi VM
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300309. PubMed ID: 37691073
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II.
Srivastava DK; Jude KM; Banerjee AL; Haldar M; Manokaran S; Kooren J; Mallik S; Christianson DW
J Am Chem Soc; 2007 May; 129(17):5528-37. PubMed ID: 17407288
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma.
Tawfik HO; Saleh MM; Ammara A; Khaleel EF; Badi R; Khater YTT; Rasheed RA; Attia AA; Hefny SM; Elkaeed EB; Nocentini A; Supuran CT; Eldehna WM; Shaldam MA
J Med Chem; 2024 Jan; 67(2):1611-1623. PubMed ID: 38207099
[TBL] [Abstract][Full Text] [Related]
14. Explainable artificial intelligence in the design of selective carbonic anhydrase I-II inhibitors via molecular fingerprinting.
Kırboğa KK; Işık M
J Comput Chem; 2024 Jul; 45(18):1530-1539. PubMed ID: 38491535
[TBL] [Abstract][Full Text] [Related]
15. One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes.
Vannozzi G; Vullo D; Angeli A; Ferraroni M; Combs J; Lomelino C; Andring J; Mckenna R; Bartolucci G; Pallecchi M; Lucarini L; Sgambellone S; Masini E; Carta F; Supuran CT
J Med Chem; 2022 Jan; 65(1):824-837. PubMed ID: 34958217
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamides stimulate ROS formation upon glycation of human carbonic anhydrase II.
Alaei L; Ashengroph M; Moosavi-Movahedi AA
Int J Biol Macromol; 2024 Jan; 255():128294. PubMed ID: 37992931
[TBL] [Abstract][Full Text] [Related]
17. Antileishmanial activity of sulphonamide nanoemulsions targeting the β-carbonic anhydrase from Leishmania species.
da Silva Cardoso V; Vermelho AB; Ricci Junior E; Almeida Rodrigues I; Mazotto AM; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):850-857. PubMed ID: 29708476
[TBL] [Abstract][Full Text] [Related]
18. New Carbonic Anhydrase-II Inhibitors from Marine Macro Brown Alga
Rafiq K; Khan A; Ur Rehman N; Halim SA; Khan M; Ali L; Hilal Al-Balushi A; Al-Busaidi HK; Al-Harrasi A
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885658
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitors.
Al-Jaidi BA; Deb PK; Telfah ST; Dakkah AN; Bataineh YA; Khames Aga QAA; Al-Dhoun MA; Ahmad Al-Subeihi AA; Odetallah HM; Bardaweel SK; Mailavaram R; Venugopala KN; Nair AB
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1483-1490. PubMed ID: 32635773
[TBL] [Abstract][Full Text] [Related]
20. The anticancer therapeutic potential of pyrimidine-sulfonamide hybrids.
Zhang P; Shi C; Dong T; Song J; Du G
Future Med Chem; 2024; 16(9):905-924. PubMed ID: 38624011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
